Pharmabiz23m
AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer
AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer: North Chicago, Illinois Tuesday, November 19, 2024, 10:00 Hrs [IST] ...
Pharmabiz1h
European Union recommends approval of AstraZeneca’s Tagrisso for patients with unresectable EGFR-mutated lung cancer
AstraZeneca’s Tagrisso (osimertinib) has been recommended for approval in the European Union (EU) for the treatment of adult patients with locally advanced, unresectable non-small cell lung cancer ...
Pharmabiz2h
Independent labs play crucial role in various stages of drug development: Dr. Saurabh Arora
In the pharmaceutical industry, ensuring the safety, efficacy, and quality of drugs is an ongoing and intricate process. Independent testing laboratories, like Auriga Research, play a critical role ...
Pharmabiz2h
Only 4 out of 46 companies inspected showed 100% compliance with Revised Schedule M in Tamil Nadu
Only 4 out of 46 companies inspected showed 100% compliance with Revised Schedule M in Tamil Nadu: Peethaambaran Kunnathoor, Chennai Tuesday, November 19, 2024, 08:00 Hrs [IST] In ...
Pharmabiz2h
DGFT overhauls export policy through harmonisation with ITC (HS) 2022 to streamline pharma export process
DGFT overhauls export policy through harmonisation with ITC (HS) 2022 to streamline pharma export process: Shardul Nautiyal, Mumbai Tuesday, November 19, 2024, 08:00 Hrs [IST] Wit ...
Pharmabiz2h
Unified mechanism under FSSAI for nutraceuticals would help rather than having two authorities: Expert
Unified mechanism under FSSAI for nutraceuticals would help rather than having two authorities: Expert: Gireesh Babu, New Delhi Tuesday, November 19, 2024, 08:00 Hrs [IST] A unifi ...
Pharmabiz2h
SEC recommends approval of additional indication for BMS' anti-cancer drug nivolumab
SEC recommends approval of additional indication for BMS' anti-cancer drug nivolumab: Gireesh Babu, New Delhi Tuesday, November 19, 2024, 08:00 Hrs [IST] The Subject Expert Commit ...
Pharmabiz11h
Molbio supports Azerbaijan's 'TB go green' initiative at COP29 with pioneering TB diagnostic solutions
As part of a concerted effort to combat tuberculosis (TB) with a focus on climate change, Molbio Diagnostics, an innovator in global healthcare has contributed a donation of their state-of-the-art TB ...
Pharmabiz16h
Boston Pharma announces positive phase 2 data on efimosfermin alfa, a long-acting FGF21 analogue in patients with stage F2/F3 fibrosis due to MASH
Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing differentiated molecules addressing serious liver diseases, announced positive results from a phase 2 study evaluating the ...
Pharmabiz18h
Augurex Life Sciences, Quest Diagnostics collaborate to improve rheumatoid arthritis diagnosis and management
Augurex Life Sciences, Quest Diagnostics collaborate to improve rheumatoid arthritis diagnosis and management: Vancouver, Canada Monday, November 18, 2024, 16:00 Hrs [IST] Augurex ...
Pharmabiz19h
Bristol Myers Squibb gets positive CHMP opinion for Opdivo plus Yervoy to treat adult with MSI-H or dMMR metastatic colorectal cancer
Bristol Myers Squibb gets positive CHMP opinion for Opdivo plus Yervoy to treat adult with MSI-H or dMMR metastatic colorectal cancer: Princeton, New Jersey Monday, November 18, 2 ...
Pharmabiz20h
EMA encourages companies to submit type I variations for 2024 by end November 2024
EMA encourages companies to submit type I variations for 2024 by end November 2024: Amsterdam, The Netherlands Monday, November 18, 2024, 14:00 Hrs [IST] European Medicines Agency ...